1. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients
    Ashraf Y. Elfert et al, 2022, Frontiers in Molecular Biosciences CrossRef
  2. Evaluation of Cellular miR-122 Expression in Association with the Presence of Varicella-Zoster Virus among Central Nervous System Tumors
    Aida Abbasi et al, 2022, International Journal of Cancer Management CrossRef
  3. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
    Guiyun Cheng et al, 2020, Frontiers in Oncology CrossRef
  4. MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2
    Jueyi Zhou et al, 2023, Biochemical Genetics CrossRef
  5. SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway
    He-Xi Wang et al, 2024, Medical Oncology CrossRef
  6. MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
    Cong Wang et al, 2020, Cancer Science CrossRef
  7. The Impact of miR-122 on Cancer
    Shijie Wu et al, 2024, Current Pharmaceutical Biotechnology CrossRef
  8. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in�vitro
    Yan Yang et al, 2018, Molecular Medicine Reports CrossRef
  9. Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?
    Karolina Orzeł-Gajowik et al, 2021, International Journal of Molecular Sciences CrossRef
  10. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
    Chen Xu et al, 2022, BMC Cancer CrossRef
  11. Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model
    Gabriela Leite et al, 2024, Gut Microbes CrossRef
  12. Applications of noncoding RNAs in renal cancer patients
    Eman A. Toraih et al, 2022, Clinical Applications of Non-Coding RNAs in Cancer CrossRef
  13. MicroRNA Signature in Renal Cell Carcinoma
    Soudeh Ghafouri-Fard et al, 2020, Frontiers in Oncology CrossRef
  14. Relationship between apical junction proteins, gene expression and cancer
    Lorenza González-Mariscal et al, 2020, Biochimica et Biophysica Acta (BBA) - Biomembranes CrossRef
  15. Prenatal arsenic exposure stymies gut butyrate production and enhances gut permeability in post natal life even in absence of arsenic deftly through miR122-Occludin pathway
    Mainak Chakraborty et al, 2023, Toxicology Letters CrossRef
  16. The landscape of miRNA-related ceRNA networks for marking different renal cell carcinoma subtypes
    Liu Qin et al, 2018, Briefings in Bioinformatics CrossRef
  17. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
    Yadi Zhou et al, 2021, Bioengineered CrossRef
  18. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
    Eleonora A. Braga et al, 2019, Frontiers in Genetics CrossRef
  19. Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1and activation of the ERK/MAPK signaling pathway
    Lei Kong et al, 2019, Cell Cycle CrossRef
  20. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
    Jonathan Xu et al, 2022, Urologic Cancers CrossRef
  21. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma
    Giovanni Cochetti et al, 2020, Scientific Reports CrossRef
  22. Clinical value of miRNA‑122 in the diagnosis and prognosis of various types of cancer
    Meiyu Dai et al, 2019, Oncology Letters CrossRef